Ivabradine is indicated in the management of:: (A) Paroxysomal supraventricular tachycardia, (B) Angina pectoris, (C) Cardiomyopathy, (D) Irritable bowel syndrome
Answer is B. Ivabradine: Bradycardiac drug. It selectively blocks If Na+ channels and reduce HR by inhibiting the hyperpolarization-activated Na+ channel in the SA node. It reduces angina attacks similar to CCBs and b blockers. Advantage of Ivabradine: Lack of effect on GI and bronchial smooth muscle.